INTRODUCTION
Post-acne scarring is a very distressing problem. Atrophic acne scars are dermal depressions commonly caused by destruction of collagen after inflammatory acne. [1] Many therapeutic measures such as chemical peeling, subcision, dermabrasion, fillers and punch techniques have been performed to improve acne scarring but with sub-optimal outcomes. [2] [3] [4] [5] [6] Ablative lasers such as Er:YAG lasers or CO 2 lasers produce significant improvement at the cost of long recovery times and post-inflammatory hyperpigmentation. [7, 8] Recently, newer techniques such as microneedling fractional radiofrequency (MFR) has been shown to be clinically efficient in managing acne scars without causing direct damage to the epidermis. [9] MFR device works by creating radiofrequency thermal zones without epidermal injury. After damage to the reticular dermis, long-term dermal remodelling, neoelastogenesis, and neocollagenogenesis results in dermal thickening. [10] MFR device was evaluated over a period of 1 year (Dec 2012 to Nov 2013) in 31 patients of skin type III-V with Grade 3 and 4 atrophic acne scars.
METHODS
A retrospective photographic analysis of 31 patients treated with MFR for facial atrophic acne scarring was done between November 2012 and December 2013. None of the patients had received any previous treatment Background: Various treatment modalities including non-invasive methods such as chemical peels, topical retinoids, microdermabrasion, minimally invasive techniques such as microneedling, fractional lasers, microneedling radiofrequency devices and invasive procedures such as acne scar surgeries and ablative lasers are used for acne scars, each with its own unique advantages and disadvantages. This study is a retrospective assessment of efficacy and safety of microneedling fractional radiofrequency in the treatment of acne scars. Methods: Thirty one patients of skin types III-V with moderate and severe facial acne scarring received four sequential fractional radiofrequency treatments over a period of 6 months with an interval of 6 weeks between each session. Goodman & Baron's acne scar grading system was used for assessment by a side by side comparison of preoperative and post-operative photographs taken at their first visit and at the end of 3 months after the last session. Results: Estimation of improvement with Goodman and Baron's Global Acne Scarring System showed that by qualitative assessment of 31 patients with grade 3 and grade 4 acne scars, 80.64% showed improvement by 2 grades and 19.35% showed improvement by 1 grade. Quantitative assessment showed that 58% of the patients had moderate, 29% had minimal, 9% had good and 3% showed very good improvement. Adverse effects were limited to transient pain, erythema, edema and hyperpigmentation. Conclusion: Microneedling fractional radiofrequency is efficacious for the treatment of moderate and severe acne scars.
for their acne scars. Patients were excluded if they had received treatment with any other lasers during treatment or follow-up period. Thirty-one patients (15 male and 16 female) met the inclusion criteria. The mean age was 27.2 years.
Patients had undergone four sessions of MFR treatment for their acne scars with an interval of 6 weeks between each session, since the time for collagen remodelling lasts around 4-6 weeks. Treatment regimen was individualised based on predominant scar type and scar depth. The procedure area was painted with povidone iodine and cleaned with rectified surgical spirit prior to the procedure.
Procedure was performed under topical anaesthesia or nerve blocks, using sterile precautions. Penetration depth was limited to 1.5 mm on forehead, temple areas and areas with bony prominences.
Patients with predominantly ice pick scars and mixed scarring were given a needle depth of 3.5 mm on the first pass, 2.5 mm on the 2 nd pass and 1.5 mm on the 3 rd pass with minimal or no overlapping.
Higher energy settings (35 W-40 W) at depths of 3.5 mm with successively lower energy levels (30 W-35 W, 25 W-30 W, respectively) were used at lower penetration depths to prevent epidermal coagulation.
Post-procedure pain was managed by oral non steroidal anti-inflammatory drugs (NSAIDs) for 2 to 5 days. Patients were advised strict sun protection along with re-epithelizing agents containing cyclopentasiloxane, cyclohexasiloxone and sodium hyaluronate.
Assessment of efficacy
Objective assessment of Physician scores of improvement was determined by global acne scarring classification of Goodman & Baron [ Tables 1 and 2a and b]. [11, 12] 
RESULTS
All patients completed the study, including the 3-month follow-ups. Most patients had mixed types of atrophic acne scars, including ice pick, boxcar and rolling scars. MFR was associated with substantial improvement in the appearance of all types of acne scars, which included Figure 3a and b]. Rolling and box scars showed better response than ice-pick scars.
Estimation of improvement with Goodman and
Baron's Global quantitative Acne Scarring System showed that 58% of the patients had moderate improvement, 29% had minimal improvement, 9% had good improvement and 3% showed very good improvement [ Figure 4 ].
The treatment was generally well tolerated. All patients underwent treatment-related pain. All patients had reported mild erythema for two days, two patients had oedema for more than three days, five patients reported post inflammatory hyperpigmentation and two patients had track marks of the device probe [ Figure 5 ]. Social activity could commence as early as one day after treatment. 
DISCUSSION
Acne scarring occurs subsequent to visible resolution of deep inflammation. Scarring may occur regardless of the severity of acne. Although acne scarring is likely to be associated more often with nodulocystic acne, it may occur in cases with only superficial forms of acne as well, especially when effective treatment is delayed. [13, 14] A study showed that approximately 16% of patients with acne seek proper treatment, and among those seeking such help, 74% wait greater than 12 months, 12% wait for 6 to 12 months, 6% wait for 6 months and only 7% wait for less than 3 months to be seen professionally for therapy of their acne. [15] Atrophic acne scarring appears to be most common type associated with acne. The major clinical types of atrophic scars are ice pick, rolling or superficial and deep soft scars, and boxcar or depressed fibrotic scars. Although ablative and non-ablative laser skin resurfacing has greatly improved the treatment of atrophic acne scars, they are not without disadvantages. [14, 16] Ablative lasers such as CO 2 and Er:YAG laser have efficacy of 25-90% for treatment of acne scars but are associated with erythema for more than 3 months, dyspigmentation and scarring. [17] Non-ablative lasers such as 1064 nm Nd YAG and 1450 nm diode lasers have an efficacy of 40-50% after a series of treatments, with effect only on shallow box scars with no significant epidermal improvement. [17, 18] In contrast to ablative and non ablative lasers, treatment with the MFR device can be controlled by varying the depth. The duration of each energy pulse can be set from 10 ms to 1,000 ms. A good control over the tissue damage can be achieved by changing the exposure time rather than altering the power level. Although the maximum power is higher than many other devices, the large range of exposure time enables the user to apply safe and consistent levels of coagulation in the dermis to achieve the desired effect. The energy delivery system consists of a disposable tip with 49 gold-plated needles. The entire length of the needle is insulated and it delivers bursts of RF energy through the tip. The depth of the needles can be adjusted from a minimum of 0.5 mm to a maximum of 3.5 mm. [19] The ability to set multiple needle depths per pass is an advantage, allowing discrete electrothermal coagulation at different layers of the dermis. The insulated needles prevent electrothermal damage from occurring anywhere in the dermis but at the very tip of the needle and never in the epidermis.
The mechanisms involved are neo-collagenogenesis by needle penetration stimulating the release of growth factors and relative sparing of epidermis and adnexal structures which contribute to rapid healing. [19] Ramesh et al. treated facial acne scars of 30 subjects with a matrix tunable radiofrequency device pretreated with oral antibiotics, topical tretinoin and subcision. The visual analog scale of improvement in scars ranged from 10-50% at end of 2 months to 20-70% at the end of 6 months. [20] Despite these differences both studies show that fractional radiofrequency is both safe and effective for treatment of acne scars in skin types 3, 4 and 5.
Gold et al., conducted a study where in 13 patients with mild to moderate acne scars were treated with bipolar fractional radiofrequency and concluded that fractional bipolar radiofrequency is safe and an effective treatment for acne scars with 67-92% patients satisfied with the results. [9] Cho et al. evaluated efficacy of fractional radiofrequency in treatment of 30 patients with mild to moderate acne scars and large facial pores. The grade of acne scars and investigator global assessment of large pores improved in more than 70% of the patients.
[21]
The encouraging results prompted us to conduct retrospective analysis of efficacy and safety of MFR Estimation of improvement with Goodman and Baron's Global quantitative Acne Scarring System showed that 58% of the patients had moderate improvement, 29% had minimal improvement, 9% had good improvement and 3% showed very good improvement Hence, all 31 patients (100%) showed improvement in their scars with no failure rate.
The treatment was well tolerated with transient side effects such as mild erythema, post-inflammatory hyperpigmentation and track marks of the device.
